Associated Banc-Corp’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $421K | Sell |
5,081
-5,647
| -53% | -$468K | 0.01% | 246 |
|
|
2025
Q1 | $870K | Sell |
10,728
-869
| -7% | -$70.5K | 0.03% | 209 |
|
|
2024
Q4 | $1.04M | Sell |
11,597
-593
| -5% | -$53.4K | 0.03% | 198 |
|
|
2024
Q3 | $1.2M | Sell |
12,190
-13
| -0.1% | -$1.28K | 0.04% | 198 |
|
|
2024
Q2 | $1.13M | Buy |
12,203
+68
| +0.6% | +$6.3K | 0.04% | 194 |
|
|
2024
Q1 | $1.15M | Buy |
12,135
+1,427
| +13% | +$135K | 0.04% | 195 |
|
|
2023
Q4 | $956K | Sell |
10,708
-362
| -3% | -$32.3K | 0.03% | 204 |
|
|
2023
Q3 | $808K | Sell |
11,070
-55
| -0.5% | -$4.02K | 0.03% | 213 |
|
|
2023
Q2 | $926K | Buy |
11,125
+35
| +0.3% | +$2.91K | 0.04% | 205 |
|
|
2023
Q1 | $845K | Buy |
11,090
+4,160
| +60% | +$317K | 0.03% | 209 |
|
|
2022
Q4 | $575K | Buy |
6,930
+627
| +10% | +$52K | 0.02% | 220 |
|
|
2022
Q3 | $500K | Buy |
6,303
+114
| +2% | +$9.04K | 0.02% | 220 |
|
|
2022
Q2 | $460K | Buy |
+6,189
| New | +$460K | 0.02% | 230 |
|